CG ONCOLOGY INC (CGON) Stock Earnings & Estimates
USA - NASDAQ:CGON - US1569441009 - Common Stock
37.54 USD
+1.06 (+2.91%)
37.54 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 191K -98.16% | 204K 6.81% | 1.139M 458.33% | 224.145K -80.32% | 95.764M 42,624.13% | 171.27M 78.85% | 463.93M 170.88% | 784.35M 69.07% | 1.188B 51.46% | 1.548B 30.30% | 1.912B 23.51% | |
| EBITDA YoY % growth | -35.231M -179.70% | -55.432M -57.34% | -114.634M -106.80% | -195.511M -70.55% | -200.189M -2.39% | -191.249M 4.47% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.246M -179.60% | -55.449M -57.32% | -114.666M -106.80% | -199.048M -73.59% | -213.981M -7.50% | -127.526M 40.40% | 24.915M 119.54% | 253.37M 916.94% | 563.04M 122.22% | 813.97M 44.57% | 1.073B 31.82% | |
| Operating Margin | -18,453.40% | -27,180.88% | -10,067.25% | -88,803.44% | -223.45% | -74.46% | 5.37% | 32.30% | 47.39% | 52.58% | 56.12% | |
| EPS YoY % growth | N/A | N/A | -1.42 -4.48% | -2.20 -54.58% | -2.31 -5.10% | -1.77 23.42% | 0.85 147.92% | 2.99 253.01% | 5.39 80.38% | 6.75 25.26% | 7.99 18.35% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.57 -91.02% | -0.60 -25.18% | -0.63 -40.53% | -0.75 -39.78% | -0.75 -30.53% | -0.83 -37.50% |
| Revenue Q2Q % growth | 74.011K 72.12% | 640.672K 40.50% | -100.00% | 5.1M 6,790.85% | 15.3M 2,288.12% | |
| EBITDA Q2Q % growth | -51.401M -81.87% | -55.1M -44.94% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -51.351M -81.48% | -54.67M -43.68% | -54.783M -29.80% | -59.007M -21.06% | -60.996M -18.78% | -65.586M -19.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.54 -92.86% | -0.47 | -0.07 | -15.32% |
| Q1 2025 Q2Q % growth | -0.45 -25.00% | -0.41 | -0.04 | -9.38% |
| Q4 2024 Q2Q % growth | -0.48 89.02% | -0.36 | -0.12 | -33.19% |
| Q3 2024 Q2Q % growth | -0.30 | -0.37 | 0.07 | 19.89% |
| Q2 2024 Q2Q % growth | -0.28 | -0.38 | 0.10 | 26.21% |
| Q1 2024 Q2Q % growth | -0.36 | -0.30 | -0.06 | -21.70% |
| Q4 2023 Q2Q % growth | -4.37 | -0.69 | -3.68 | -534.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 126.103K | -126.103K | -100.00% |
| Q1 2025 Q2Q % growth | 52K -90.17% | 217.005K | -165.005K | -76.04% |
| Q4 2024 Q2Q % growth | 456K 45,500.00% | 76.5K | 379.5K | 496.08% |
| Q3 2024 Q2Q % growth | 43K -78.82% | 106.284K | -63.284K | -59.54% |
| Q2 2024 Q2Q % growth | 111K | 179.857K | -68.857K | -38.28% |
| Q3 2023 Q2Q % growth | 203K 6.28% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.52% | -20.97% | -0.03% | -15.54% |
| Revenue | -22.22% | -49.38% | -52.17% | -50.44% |